Literature DB >> 19856135

Coronary angiographic studies of impaired glucose regulation and coronary artery disease in Chinese nondiabetic subjects.

Qun Yan1, Wei Q Gu, Jie Hong, Yi F Zhang, Yu X Su, Ming H Gui, Yu Zhang, Zhen N Chi, Yu W Zhang, Xiao Y Li, Guang Ning.   

Abstract

To investigate the prevalence and the extent of coronary artery disease (CAD) in nondiabetic Chinese patients with different categories of impaired glucose regulation (IGR): isolated impaired fasting glucose (I-IFG); isolated impaired glucose tolerance (I-IGT); and combined IFG and IGT (CGI). A total of 556 nondiabetic subjects who had undergone coronary angiography were included in this study. Subjects were classified according to the 75-g oral glucose tolerance test result: normal glucose tolerance (NGT) (n = 278), I-IFG (n = 52), I-IGT (n = 128), CGI (n = 98). Significant CAD is defined as the presence of one or more coronary vessels with the lumeninal reduction in diameter to ≥50% in a given subject. The severity and extent of coronary atherosclerosis are defined by the Gensini score, the worst artery score, and the number of diseased vessels with significant coronary stenosis (number of diseased vessels). The prevalence of significant CAD in I-IFG and I-IGT groups were similar (67.3%, P = 0.207; 67.4%, P = 0.068, respectively) but both were higher comparing with NGT group (57.9%), however, it was considerably higher in CGI group (85.9%, P < 0.001). The Gensini score, worst artery score, and number of diseased vessels were similar in NGT, I-IFG, and I-IGT groups, but all significantly increased in CGI group after adjustment for other traditional factors (all P < 0.001). Logistic regression analyses reveal fasting glucose but not 2-h glucose as a significant determinant in Gensini score, worst artery score, and number of diseased vessels. The prevalence and the extent of CAD did not differ significantly among subjects with NGT, I-IFG, and I-IGT, but increased significantly in those with CGI. Fasting glucose was more strongly associated with angiographically characterized coronary artery stenosis than 2-h glucose.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19856135     DOI: 10.1007/s12020-009-9261-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  19 in total

Review 1.  Postprandial blood glucose. American Diabetes Association.

Authors: 
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

2.  Glucose tolerance status and severity of coronary artery disease in men referred to coronary arteriography.

Authors:  M Seibaek; C Sloth; L Vallebo; T Hansen; S A Urhammer; H Burchardt; C Torp-Pedersen; O Pedersen; P Hildebrandt
Journal:  Am Heart J       Date:  1997-06       Impact factor: 4.749

3.  Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.

Authors:  M Hanefeld; S Fischer; U Julius; J Schulze; U Schwanebeck; H Schmechel; H J Ziegelasch; J Lindner
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

4.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

Authors:  M Coutinho; H C Gerstein; Y Wang; S Yusuf
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

5.  Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.

Authors:  Emily B Levitan; Yiqing Song; Earl S Ford; Simin Liu
Journal:  Arch Intern Med       Date:  2004-10-25

6.  Quantitative coronary angiographic studies of patients with angina pectoris and impaired glucose tolerance.

Authors:  Yu Kataoka; Satoshi Yasuda; Isao Morii; Yoritaka Otsuka; Atsushi Kawamura; Shunichi Miyazaki
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

7.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

8.  Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.

Authors:  Mattie Lenzen; Lars Ryden; John Ohrvik; Malgorzata Bartnik; Klas Malmberg; Wilma Scholte Op Reimer; Maarten L Simoons
Journal:  Eur Heart J       Date:  2006-11-07       Impact factor: 29.983

9.  Impaired fasting glucose and the prevalence and severity of angiographic coronary artery disease in high-risk Chinese patients.

Authors:  Xuehong Dong; Linuo Zhou; Yingjiu Zhai; Bin Lu; Dong Wang; Haiming Shi; Xinping Luo; Weihu Fan; Renming Hu
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

10.  Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.

Authors:  Paul G H Janssen; Kees J Gorter; Ronald P Stolk; Guy E H M Rutten
Journal:  Prim Care Diabetes       Date:  2007-03-29       Impact factor: 2.459

View more
  4 in total

1.  The association between platelet/lymphocyte ratio and coronary artery disease severity.

Authors:  Murat Yüksel; Abdulkadir Yıldız; Mustafa Oylumlu; Abdurrahman Akyüz; Mesut Aydın; Hasan Kaya; Halit Acet; Nihat Polat; Mehmet Zihni Bilik; Sait Alan
Journal:  Anatol J Cardiol       Date:  2014-07-11       Impact factor: 1.596

2.  Elevated 1-h postload plasma glucose levels identify coronary heart disease patients with greater severity of coronary artery lesions and higher risk of 1-year re-admission.

Authors:  Lifei Cao; Ping Wang; Hui Luan; Hui Chen; Chaodi Luo; Danjun Zhu; Gang Tian
Journal:  Diab Vasc Dis Res       Date:  2020 Jan-Feb       Impact factor: 3.291

3.  Association of Impaired Fasting Blood Glucose With Triple Coronary Artery Stenosis and Myocardial Infarction Among Patients With Coronary Artery Stenosis.

Authors:  Chang Chen; Yequn Chen; Jiaxin Xiao; Yanhong Zhang; Zhaorui Yang; Peixuan Yang; Nan Lu; Kaihong Yi; Xiaojun Chen; Shaoxin Chen; Mary Clare O'Gara MSc; Michael O'Meara; Shu Ye; Xuerui Tan
Journal:  Front Cell Dev Biol       Date:  2022-03-03

4.  Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.

Authors:  Seyyed Saeed Moazzeni; Hamidreza Ghafelehbashi; Mitra Hasheminia; Donna Parizadeh; Arash Ghanbarian; Fereidoun Azizi; Farzad Hadaegh
Journal:  BMC Public Health       Date:  2020-10-06       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.